MariMed, Inc. (MRMD)
0.0471
0.00 (0.00%)
USD |
OTCM |
Nov 20, 16:00
MariMed Net Income (Quarterly) : -3.487M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -3.487M |
| June 30, 2026 | -3.571M |
| March 31, 2026 | -3.767M |
| December 31, 2025 | -4.641M |
| September 30, 2025 | -2.941M |
| June 30, 2025 | -1.395M |
| March 31, 2025 | -5.479M |
| December 31, 2024 | -8.264M |
| September 30, 2024 | -0.995M |
| June 30, 2024 | -1.639M |
| March 31, 2024 | -1.292M |
| December 31, 2023 | -10.14M |
| September 30, 2023 | -4.269M |
| June 30, 2023 | -0.981M |
| March 31, 2023 | -0.664M |
| December 31, 2022 | 4.755M |
| September 30, 2022 | 2.722M |
| June 30, 2022 | 1.896M |
| March 31, 2022 | 4.241M |
| December 31, 2021 | -6.398M |
| September 30, 2021 | 2.123M |
| June 30, 2021 | 7.589M |
| March 31, 2021 | 4.31M |
| December 31, 2020 | 4.212M |
| September 30, 2020 | 1.696M |
| Date | Value |
|---|---|
| June 30, 2020 | -1.141M |
| March 31, 2020 | -2.338M |
| December 31, 2019 | -79.38M |
| September 30, 2019 | -7.300M |
| June 30, 2019 | 4.723M |
| March 31, 2019 | 0.078M |
| December 31, 2018 | 4.913M |
| September 30, 2018 | -3.412M |
| June 30, 2018 | -0.3927M |
| March 31, 2018 | -1.832M |
| December 31, 2017 | -1.329M |
| September 30, 2017 | -0.314M |
| June 30, 2017 | 0.5048M |
| March 31, 2017 | 0.1094M |
| December 31, 2016 | 0.3486M |
| September 30, 2016 | -0.0069M |
| June 30, 2016 | 0.039M |
| March 31, 2016 | -0.0618M |
| December 31, 2015 | -1.060M |
| September 30, 2015 | -0.0569M |
| June 30, 2015 | -0.4111M |
| March 31, 2015 | -0.319M |
| December 31, 2014 | -0.5258M |
| September 30, 2014 | -6.638M |
| June 30, 2014 | -0.1252M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cencora, Inc. | 529.10M |
| Acme United Corp. | 3.435M |
| ANI Pharmaceuticals, Inc. | 32.72M |
| Cardinal Health, Inc. | 556.00M |
| Corcept Therapeutics, Inc. | 124.49M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 44.23M |
| Total Expenses (Quarterly) | 47.73M |
| EPS Diluted (Quarterly) | -0.0087 |
| Enterprise Value | 104.20M |
| Gross Profit Margin (Quarterly) | 20.84% |
| Profit Margin (Quarterly) | -7.88% |
| Earnings Yield | -82.59% |
| Normalized Earnings Yield | -83.01 |